News Concordia hiked drug price by 6,000%, says UK watchdog CMA provisionally finds Concordia overpriced thyroid drug.
News Concordia and Actavis face UK pricing probe Firms colluded to hike prices, says competition watchdog.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
